ID   PGM2_HUMAN              Reviewed;         612 AA.
AC   Q96G03; B4E0G8; Q53FP5; Q5QTR0; Q9H0P9; Q9NV22;
DT   19-JUL-2005, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 4.
DT   10-MAY-2017, entry version 148.
DE   RecName: Full=Phosphoglucomutase-2;
DE            Short=PGM 2;
DE            EC=5.4.2.2;
DE   AltName: Full=Glucose phosphomutase 2;
DE   AltName: Full=Phosphodeoxyribomutase;
DE   AltName: Full=Phosphopentomutase;
DE            EC=5.4.2.7;
GN   Name=PGM2; ORFNames=MSTP006;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Kidney;
RX   PubMed=11230166; DOI=10.1101/gr.GR1547R;
RA   Wiemann S., Weil B., Wellenreuther R., Gassenhuber J., Glassl S.,
RA   Ansorge W., Boecher M., Bloecker H., Bauersachs S., Blum H.,
RA   Lauber J., Duesterhoeft A., Beyer A., Koehrer K., Strack N.,
RA   Mewes H.-W., Ottenwaelder B., Obermaier B., Tampe J., Heubner D.,
RA   Wambutt R., Korn B., Klein M., Poustka A.;
RT   "Towards a catalog of human genes and proteins: sequencing and
RT   analysis of 500 novel complete protein coding human cDNAs.";
RL   Genome Res. 11:422-435(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Aorta;
RA   Hui R.T., Liu Y.Q., Liu B., Zhao B., Meng X.M., Sheng H., Xu Y.Y.,
RA   Wang X.Y., Ye J., Song L., Gao Y., Wei Y.J., Zhang C.L., Zhang J.,
RA   Chai M.Q., Chen J.Z., Sun Y.H., Zhou X.L., Jiang Y.X., Zhao X.W.,
RA   Liu S., Cao H.Q., Zhao Y., Liu D.Q., Ding J.F., Liu L.S., Gao R.L.,
RA   Wu Q.Y., Qiang B.Q., Yuan J.G., Liew C.C., Zhao M.S.;
RL   Submitted (NOV-1998) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Thymus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   ASP-10.
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Gastric mucosa;
RA   Suzuki Y., Sugano S., Totoki Y., Toyoda A., Takeda T., Sakaki Y.,
RA   Tanaka A., Yokoyama S.;
RL   Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   ASP-10.
RC   TISSUE=Muscle;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   PROTEIN SEQUENCE OF 2-14, AND ACETYLATION AT ALA-2.
RC   TISSUE=Platelet;
RX   PubMed=12665801; DOI=10.1038/nbt810;
RA   Gevaert K., Goethals M., Martens L., Van Damme J., Staes A.,
RA   Thomas G.R., Vandekerckhove J.;
RT   "Exploring proteomes and analyzing protein processing by mass
RT   spectrometric identification of sorted N-terminal peptides.";
RL   Nat. Biotechnol. 21:566-569(2003).
RN   [9]
RP   FUNCTION, IDENTIFICATION BY MASS SPECTROMETRY, AND BIOPHYSICOCHEMICAL
RP   PROPERTIES.
RX   PubMed=17804405; DOI=10.1074/jbc.M706818200;
RA   Maliekal P., Sokolova T., Vertommen D., Veiga-da-Cunha M.,
RA   Van Schaftingen E.;
RT   "Molecular identification of mammalian phosphopentomutase and glucose-
RT   1,6-bisphosphate synthase, two members of the alpha-D-
RT   phosphohexomutase family.";
RL   J. Biol. Chem. 282:31844-31851(2007).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-165, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [11]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [14]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.M111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C.,
RA   Meinnel T., Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [15]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-165, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-165, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: Catalyzes the conversion of the nucleoside breakdown
CC       products ribose-1-phosphate and deoxyribose-1-phosphate to the
CC       corresponding 5-phosphopentoses. May also catalyze the
CC       interconversion of glucose-1-phosphate and glucose-6-phosphate.
CC       Has low glucose 1,6-bisphosphate synthase activity.
CC       {ECO:0000269|PubMed:17804405}.
CC   -!- CATALYTIC ACTIVITY: Alpha-D-glucose 1-phosphate = alpha-D-glucose
CC       6-phosphate.
CC   -!- CATALYTIC ACTIVITY: Alpha-D-ribose 1-phosphate = D-ribose 5-
CC       phosphate.
CC   -!- CATALYTIC ACTIVITY: 2-deoxy-alpha-D-ribose 1-phosphate = 2-deoxy-
CC       alpha-D-ribose 5-phosphate.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000250};
CC       Note=Binds 1 Mg(2+) ion per subunit. {ECO:0000250};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=45.7 uM for alpha-D-ribose 1-phosphate
CC         {ECO:0000269|PubMed:17804405};
CC         KM=4.1 uM for 2-deoxy-alpha-D-ribose 1-phosphate
CC         {ECO:0000269|PubMed:17804405};
CC         KM=114 uM for alpha-D-glucose 1-phosphate
CC         {ECO:0000269|PubMed:17804405};
CC         Vmax=104.3 umol/min/mg enzyme with alpha-D-ribose 1-phosphate as
CC         substrate {ECO:0000269|PubMed:17804405};
CC         Vmax=20.8 umol/min/mg enzyme with 2-deoxy-alpha-D-ribose 1-
CC         phosphate as substrate {ECO:0000269|PubMed:17804405};
CC         Vmax=22.8 umol/min/mg enzyme with alpha-D-glucose 1-phosphate as
CC         substrate {ECO:0000269|PubMed:17804405};
CC   -!- PATHWAY: Carbohydrate degradation; 2-deoxy-D-ribose 1-phosphate
CC       degradation; D-glyceraldehyde 3-phosphate and acetaldehyde from 2-
CC       deoxy-alpha-D-ribose 1-phosphate: step 1/2.
CC   -!- INTERACTION:
CC       P04792:HSPB1; NbExp=2; IntAct=EBI-4399372, EBI-352682;
CC       Q9BSI4:TINF2; NbExp=2; IntAct=EBI-4399372, EBI-717399;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q96G03-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q96G03-2; Sequence=VSP_056221, VSP_056222, VSP_056223,
CC                                  VSP_056224;
CC         Note=No experimental confirmation available.;
CC   -!- SIMILARITY: Belongs to the phosphohexose mutase family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AL136705; CAB66640.1; -; mRNA.
DR   EMBL; AF109360; AAQ13508.1; -; mRNA.
DR   EMBL; AK001845; BAA91938.1; -; mRNA.
DR   EMBL; AK303374; BAG64430.1; -; mRNA.
DR   EMBL; CR457274; CAG33555.1; -; mRNA.
DR   EMBL; AK223237; BAD96957.1; -; mRNA.
DR   EMBL; AC021106; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC108022; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC010087; AAH10087.1; -; mRNA.
DR   CCDS; CCDS3443.1; -. [Q96G03-1]
DR   RefSeq; NP_060760.2; NM_018290.3. [Q96G03-1]
DR   UniGene; Hs.23363; -.
DR   UniGene; Hs.607816; -.
DR   ProteinModelPortal; Q96G03; -.
DR   BioGrid; 120564; 14.
DR   IntAct; Q96G03; 5.
DR   STRING; 9606.ENSP00000371393; -.
DR   iPTMnet; Q96G03; -.
DR   PhosphoSitePlus; Q96G03; -.
DR   SwissPalm; Q96G03; -.
DR   BioMuta; PGM2; -.
DR   DMDM; 116242708; -.
DR   EPD; Q96G03; -.
DR   MaxQB; Q96G03; -.
DR   PaxDb; Q96G03; -.
DR   PeptideAtlas; Q96G03; -.
DR   PRIDE; Q96G03; -.
DR   Ensembl; ENST00000381967; ENSP00000371393; ENSG00000169299. [Q96G03-1]
DR   GeneID; 55276; -.
DR   KEGG; hsa:55276; -.
DR   UCSC; uc011byb.2; human. [Q96G03-1]
DR   CTD; 55276; -.
DR   GeneCards; PGM2; -.
DR   HGNC; HGNC:8906; PGM2.
DR   HPA; HPA040676; -.
DR   MIM; 172000; gene.
DR   neXtProt; NX_Q96G03; -.
DR   OpenTargets; ENSG00000169299; -.
DR   PharmGKB; PA33243; -.
DR   eggNOG; KOG1220; Eukaryota.
DR   eggNOG; COG1109; LUCA.
DR   GeneTree; ENSGT00390000017247; -.
DR   HOGENOM; HOG000268676; -.
DR   HOVERGEN; HBG056917; -.
DR   InParanoid; Q96G03; -.
DR   KO; K15779; -.
DR   OMA; PLLHDPY; -.
DR   OrthoDB; EOG091G040C; -.
DR   PhylomeDB; Q96G03; -.
DR   TreeFam; TF300692; -.
DR   BioCyc; MetaCyc:HS09924-MONOMER; -.
DR   Reactome; R-HSA-3322077; Glycogen synthesis.
DR   Reactome; R-HSA-6798695; Neutrophil degranulation.
DR   Reactome; R-HSA-70221; Glycogen breakdown (glycogenolysis).
DR   Reactome; R-HSA-70370; Galactose catabolism.
DR   Reactome; R-HSA-71336; Pentose phosphate pathway (hexose monophosphate shunt).
DR   SABIO-RK; Q96G03; -.
DR   UniPathway; UPA00002; UER00467.
DR   ChiTaRS; PGM2; human.
DR   GeneWiki; PGM2; -.
DR   GenomeRNAi; 55276; -.
DR   PRO; PR:Q96G03; -.
DR   Proteomes; UP000005640; Chromosome 4.
DR   Bgee; ENSG00000169299; -.
DR   CleanEx; HS_PGM2; -.
DR   ExpressionAtlas; Q96G03; baseline and differential.
DR   Genevisible; Q96G03; HS.
DR   GO; GO:0005829; C:cytosol; IBA:GO_Central.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:1904813; C:ficolin-1-rich granule lumen; TAS:Reactome.
DR   GO; GO:0034774; C:secretory granule lumen; TAS:Reactome.
DR   GO; GO:0000287; F:magnesium ion binding; IEA:InterPro.
DR   GO; GO:0004614; F:phosphoglucomutase activity; EXP:Reactome.
DR   GO; GO:0008973; F:phosphopentomutase activity; IDA:UniProtKB.
DR   GO; GO:0046386; P:deoxyribose phosphate catabolic process; IEA:UniProtKB-UniPathway.
DR   GO; GO:0019388; P:galactose catabolic process; TAS:Reactome.
DR   GO; GO:0006006; P:glucose metabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0005978; P:glycogen biosynthetic process; TAS:Reactome.
DR   GO; GO:0005980; P:glycogen catabolic process; TAS:Reactome.
DR   GO; GO:0043312; P:neutrophil degranulation; TAS:Reactome.
DR   GO; GO:0006098; P:pentose-phosphate shunt; TAS:Reactome.
DR   Gene3D; 3.30.310.50; -; 1.
DR   InterPro; IPR005844; A-D-PHexomutase_a/b/a-I.
DR   InterPro; IPR016055; A-D-PHexomutase_a/b/a-I/II/III.
DR   InterPro; IPR005845; A-D-PHexomutase_a/b/a-II.
DR   InterPro; IPR005846; A-D-PHexomutase_a/b/a-III.
DR   InterPro; IPR005843; A-D-PHexomutase_C.
DR   InterPro; IPR016066; A-D-PHexomutase_CS.
DR   InterPro; IPR005841; Alpha-D-phosphohexomutase_SF.
DR   Pfam; PF02878; PGM_PMM_I; 1.
DR   Pfam; PF02879; PGM_PMM_II; 1.
DR   Pfam; PF02880; PGM_PMM_III; 1.
DR   Pfam; PF00408; PGM_PMM_IV; 1.
DR   PRINTS; PR00509; PGMPMM.
DR   SUPFAM; SSF53738; SSF53738; 3.
DR   SUPFAM; SSF55957; SSF55957; 1.
DR   PROSITE; PS00710; PGM_PMM; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Carbohydrate metabolism;
KW   Complete proteome; Cytoplasm; Direct protein sequencing;
KW   Glucose metabolism; Isomerase; Magnesium; Metal-binding;
KW   Phosphoprotein; Polymorphism; Reference proteome.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:19413330,
FT                                ECO:0000244|PubMed:22223895,
FT                                ECO:0000244|PubMed:22814378,
FT                                ECO:0000269|PubMed:12665801}.
FT   CHAIN         2    612       Phosphoglucomutase-2.
FT                                /FTId=PRO_0000147781.
FT   REGION      165    166       Substrate binding.
FT                                {ECO:0000250|UniProtKB:P00949}.
FT   REGION      326    327       Substrate binding.
FT                                {ECO:0000250|UniProtKB:P00949}.
FT   REGION      424    426       Substrate binding.
FT                                {ECO:0000250|UniProtKB:P00949}.
FT   ACT_SITE    165    165       Phosphoserine intermediate.
FT                                {ECO:0000250|UniProtKB:P00949}.
FT   METAL       165    165       Magnesium; via phosphate group.
FT                                {ECO:0000250|UniProtKB:P00949}.
FT   METAL       322    322       Magnesium.
FT                                {ECO:0000250|UniProtKB:P00949}.
FT   METAL       324    324       Magnesium.
FT                                {ECO:0000250|UniProtKB:P00949}.
FT   METAL       326    326       Magnesium.
FT                                {ECO:0000250|UniProtKB:P00949}.
FT   BINDING      59     59       Substrate.
FT                                {ECO:0000250|UniProtKB:P00949}.
FT   BINDING      63     63       Substrate.
FT                                {ECO:0000250|UniProtKB:P00949}.
FT   BINDING     400    400       Substrate.
FT                                {ECO:0000250|UniProtKB:P00949}.
FT   BINDING     438    438       Substrate.
FT                                {ECO:0000250|UniProtKB:P00949}.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000244|PubMed:19413330,
FT                                ECO:0000244|PubMed:22223895,
FT                                ECO:0000244|PubMed:22814378,
FT                                ECO:0000269|PubMed:12665801}.
FT   MOD_RES     165    165       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   VAR_SEQ       1      8       MAAPEGSG -> MSSQLILR (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_056221.
FT   VAR_SEQ       9    147       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_056222.
FT   VAR_SEQ     429    430       YM -> KK (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_056223.
FT   VAR_SEQ     431    612       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_056224.
FT   VARIANT      10     10       G -> D (in dbSNP:rs17856324).
FT                                {ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|Ref.4}.
FT                                /FTId=VAR_027968.
FT   VARIANT     488    488       E -> D (in dbSNP:rs10001580).
FT                                /FTId=VAR_027969.
FT   CONFLICT    114    114       G -> A (in Ref. 5; BAD96957).
FT                                {ECO:0000305}.
FT   CONFLICT    162    162       I -> V (in Ref. 2; BAA91938).
FT                                {ECO:0000305}.
FT   CONFLICT    282    282       K -> R (in Ref. 1; CAB66640).
FT                                {ECO:0000305}.
FT   CONFLICT    495    495       E -> G (in Ref. 5; BAD96957).
FT                                {ECO:0000305}.
SQ   SEQUENCE   612 AA;  68283 MW;  82234DDE810D1F52 CRC64;
     MAAPEGSGLG EDARLDQETA QWLRWDKNSL TLEAVKRLIA EGNKEELRKC FGARMEFGTA
     GLRAAMGPGI SRMNDLTIIQ TTQGFCRYLE KQFSDLKQKG IVISFDARAH PSSGGSSRRF
     ARLAATTFIS QGIPVYLFSD ITPTPFVPFT VSHLKLCAGI MITASHNPKQ DNGYKVYWDN
     GAQIISPHDK GISQAIEENL EPWPQAWDDS LIDSSPLLHN PSASINNDYF EDLKKYCFHR
     SVNRETKVKF VHTSVHGVGH SFVQSAFKAF DLVPPEAVPE QKDPDPEFPT VKYPNPEEGK
     GVLTLSFALA DKTKARIVLA NDPDADRLAV AEKQDSGEWR VFSGNELGAL LGWWLFTSWK
     EKNQDRSALK DTYMLSSTVS SKILRAIALK EGFHFEETLT GFKWMGNRAK QLIDQGKTVL
     FAFEEAIGYM CCPFVLDKDG VSAAVISAEL ASFLATKNLS LSQQLKAIYV EYGYHITKAS
     YFICHDQETI KKLFENLRNY DGKNNYPKAC GKFEISAIRD LTTGYDDSQP DKKAVLPTSK
     SSQMITFTFA NGGVATMRTS GTEPKIKYYA ELCAPPGNSD PEQLKKELNE LVSAIEEHFF
     QPQKYNLQPK AD
//
